Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Genes and Cancer | journal | 1.883 Q2 | 81 | 11 | 67 | 779 | 337 | 66 | 5.59 | 70.82 | 46.43 | |
52 | Frontiers in Oncology | journal | 1.834 Q2 | 136 | 2896 | 2367 | 161571 | 13935 | 2301 | 5.76 | 55.79 | 42.49 | |
53 | Cancer journal (Sudbury, Mass.) | journal | 1.825 Q2 | 102 | 76 | 181 | 5317 | 634 | 161 | 2.96 | 69.96 | 27.12 | |
54 | Cancers | journal | 1.818 Q2 | 133 | 3843 | 2723 | 302766 | 17841 | 2686 | 6.25 | 78.78 | 45.25 | |
55 | Journal of Immunotherapy | journal | 1.805 Q2 | 106 | 46 | 147 | 1371 | 734 | 147 | 4.52 | 29.80 | 44.44 | |
56 | Seminars in Radiation Oncology | journal | 1.761 Q2 | 103 | 40 | 129 | 2575 | 678 | 118 | 5.45 | 64.38 | 40.56 | |
57 | Genes Chromosomes and Cancer | journal | 1.754 Q2 | 130 | 83 | 253 | 3267 | 1091 | 246 | 4.43 | 39.36 | 41.47 | |
58 | Cellular oncology (Dordrecht) | journal | 1.698 Q2 | 58 | 81 | 165 | 5595 | 976 | 161 | 6.12 | 69.07 | 40.87 | |
59 | Targeted Oncology | journal | 1.697 Q2 | 59 | 74 | 220 | 3215 | 972 | 214 | 3.99 | 43.45 | 37.20 | |
60 | Carcinogenesis | journal | 1.688 Q2 | 223 | 172 | 452 | 8072 | 2149 | 437 | 4.07 | 46.93 | 40.10 | |
61 | Cancer Research and Treatment | journal | 1.668 Q2 | 58 | 116 | 418 | 3147 | 1878 | 417 | 4.54 | 27.13 | 39.95 | |
62 | Oncology Reviews | journal | 1.637 Q2 | 31 | 28 | 52 | 1999 | 310 | 51 | 3.62 | 71.39 | 47.62 | |
63 | Oral Oncology | journal | 1.623 Q2 | 137 | 445 | 901 | 13388 | 3676 | 728 | 3.79 | 30.09 | 36.67 | |
64 | Advances in Cancer Research | journal | 1.570 Q2 | 109 | 34 | 103 | 4898 | 609 | 13 | 5.98 | 144.06 | 0.00 | |
65 | Breast | journal | 1.563 Q2 | 98 | 183 | 547 | 6281 | 2112 | 493 | 3.66 | 34.32 | 48.79 | |
66 | Cell Death Discovery | journal | 1.556 Q2 | 58 | 133 | 312 | 7153 | 1531 | 297 | 4.65 | 53.78 | 40.69 | |
67 | Cancer Gene Therapy | journal | 1.535 Q2 | 99 | 91 | 128 | 3977 | 668 | 125 | 4.81 | 43.70 | 40.81 | |
68 | Cancer Biology and Medicine | journal | 1.517 Q2 | 62 | 76 | 160 | 5110 | 888 | 160 | 3.91 | 67.24 | 45.34 | |
69 | Epigenetics | journal | 1.515 Q2 | 111 | 119 | 280 | 7001 | 1328 | 279 | 4.33 | 58.83 | 46.45 | |
70 | Clinical Lung Cancer | journal | 1.506 Q2 | 74 | 164 | 489 | 4650 | 2008 | 463 | 4.24 | 28.35 | 36.40 | |
71 | Molecular Therapy - Oncolytics | journal | 1.424 Q2 | 42 | 153 | 149 | 7492 | 854 | 149 | 6.22 | 48.97 | 41.96 | |
72 | International Journal of Oncology | journal | 1.405 Q2 | 139 | 235 | 1092 | 14939 | 5449 | 1092 | 5.19 | 63.57 | 39.74 | |
73 | Cancer Medicine | journal | 1.403 Q2 | 84 | 863 | 1598 | 33084 | 6927 | 1594 | 4.09 | 38.34 | 40.25 | |
74 | Experimental Hematology | journal | 1.386 Q2 | 129 | 94 | 282 | 5219 | 845 | 278 | 2.78 | 55.52 | 44.88 | |
75 | BMC Cancer | journal | 1.358 Q2 | 160 | 1203 | 3415 | 45082 | 14270 | 3411 | 4.14 | 37.47 | 40.48 | |
76 | JNCI Cancer Spectrum | journal | 1.345 Q2 | 33 | 77 | 158 | 2626 | 518 | 140 | 3.36 | 34.10 | 47.52 | |
77 | Translational Oncology | journal | 1.343 Q2 | 72 | 177 | 448 | 8573 | 1887 | 448 | 4.14 | 48.44 | 39.48 | |
78 | Journal of Cancer Research and Clinical Oncology | journal | 1.338 Q2 | 109 | 296 | 778 | 12560 | 3265 | 759 | 4.25 | 42.43 | 37.69 | |
79 | Cancer Cell International | journal | 1.322 Q2 | 80 | 565 | 665 | 25161 | 3384 | 665 | 5.19 | 44.53 | 40.45 | |
80 | Apoptosis : an international journal on programmed cell death | journal | 1.318 Q2 | 128 | 68 | 258 | 3690 | 1257 | 251 | 3.78 | 54.26 | 44.35 | |
81 | Current Hematologic Malignancy Reports | journal | 1.299 Q2 | 44 | 46 | 194 | 3300 | 679 | 192 | 3.72 | 71.74 | 41.94 | |
82 | Current Opinion in Oncology | journal | 1.297 Q2 | 104 | 90 | 221 | 4728 | 748 | 207 | 3.05 | 52.53 | 40.96 | |
83 | Cancer cytopathology | journal | 1.290 Q2 | 68 | 131 | 369 | 3259 | 1188 | 266 | 3.11 | 24.88 | 49.56 | |
84 | Cancer Prevention Research | journal | 1.283 Q2 | 112 | 140 | 262 | 5264 | 948 | 254 | 2.98 | 37.60 | 51.06 | |
85 | Clinical and Experimental Metastasis | journal | 1.269 Q2 | 109 | 64 | 166 | 2792 | 651 | 151 | 4.38 | 43.63 | 33.81 | |
86 | Oncology Research | journal | 1.267 Q2 | 76 | 60 | 417 | 2201 | 1954 | 417 | 4.78 | 36.68 | 40.23 | |
87 | Epigenomics | journal | 1.265 Q2 | 77 | 154 | 371 | 9073 | 1501 | 349 | 3.96 | 58.92 | 46.96 | |
88 | Journal of Neuro-Oncology | journal | 1.256 Q2 | 135 | 281 | 1030 | 10646 | 4125 | 980 | 3.80 | 37.89 | 36.39 | |
89 | Molecular Carcinogenesis | journal | 1.254 Q2 | 107 | 120 | 584 | 6174 | 2553 | 584 | 4.41 | 51.45 | 43.21 | |
90 | Stem Cell Reviews and Reports | journal | 1.247 Q2 | 87 | 107 | 224 | 8142 | 1103 | 203 | 4.91 | 76.09 | 48.54 | |
91 | Cancer Genomics and Proteomics | journal | 1.234 Q2 | 50 | 75 | 147 | 3972 | 660 | 147 | 4.30 | 52.96 | 39.75 | |
92 | Experimental Hematology and Oncology | journal | 1.223 Q2 | 42 | 37 | 96 | 2219 | 372 | 95 | 4.33 | 59.97 | 48.34 | |
93 | Cytotherapy | journal | 1.192 Q2 | 105 | 92 | 387 | 3810 | 1671 | 355 | 4.33 | 41.41 | 45.55 | |
94 | JCO clinical cancer informatics | journal | 1.188 Q2 | 33 | 73 | 249 | 2684 | 702 | 246 | 3.09 | 36.77 | 32.71 | |
95 | Current Pathobiology Reports | journal | 1.177 Q2 | 33 | 13 | 79 | 1495 | 227 | 78 | 2.58 | 115.00 | 46.00 | |
96 | Journal of Mammary Gland Biology and Neoplasia | journal | 1.177 Q2 | 112 | 32 | 69 | 2548 | 219 | 67 | 2.53 | 79.63 | 57.24 | |
97 | Virus Research | journal | 1.175 Q2 | 144 | 267 | 767 | 15196 | 2551 | 760 | 3.15 | 56.91 | 41.04 | |
98 | Cancer Biology and Therapy | journal | 1.166 Q2 | 130 | 141 | 425 | 5232 | 1759 | 421 | 4.11 | 37.11 | 42.04 | |
99 | Cancer Epidemiology | journal | 1.156 Q2 | 86 | 163 | 465 | 5597 | 1263 | 449 | 2.72 | 34.34 | 49.12 | |
100 | Current Problems in Cancer | journal | 1.146 Q2 | 47 | 77 | 170 | 2484 | 569 | 159 | 2.97 | 32.26 | 37.50 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®